Why prevent, diagnose and treat congenital toxoplasmosis? (Q22305913)

Europe PubMed Central

title

Why prevent, diagnose and treat congenital toxoplasmosis? (English)

0 references

0 references

0 references

Rima McLeod

1

Rima

McLeod

1 reference

8 February 2023

Francois Kieffer

2

Francois

Kieffer

1 reference

8 February 2023

Mari Sautter

3

Mari

Sautter

1 reference

8 February 2023

Tiffany Hosten

4

Tiffany

Hosten

1 reference

8 February 2023

Herve Pelloux

5

Herve

Memórias do Instituto Oswaldo Cruz

Pelloux

1 reference

8 February 2023

March 2009

0 references

published in

1 reference

Toxoplasmic encephalomyelitis: III. A new case of granulomatous encephalomyelitis due to a protozoon

volume

104

0 references

page(s)

320-344

0 references

issue

2

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Toxoplasmosis in pediatric patients.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Management of Toxoplasma gondii infection during pregnancy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Fatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, clinical, and parasitological aspects

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Newborn screening for congenital toxoplasmosis: feasible, but benefits are not established

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Globalization and the population structure of Toxoplasma gondii

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Biases in observational studies of the effect of prenatal treatment for congenital toxoplasmosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Association between congenital toxoplasmosis and parent-reported developmental outcomes, concerns, and impairments, in 3 year old children

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Determinants of response to a parent questionnaire about development and behaviour in 3 year olds: European multicentre study of congenital toxoplasmosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Congenital and maternal toxoplasmosis. A review of 300 congenital cases

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Early and delayed ocu lar manifestations of congenital toxoplasmosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Treatment of uveitis with pyrimethamine (daraprim)

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Ocular toxoplasmosis: more than just what meets the eye.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

27 September 2017

Anti-toxoplasmosis drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Histopathological features of ocular toxoplasmosis in the fetus and infant.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

The child with congenital toxoplasmosis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Growth of Toxoplasma gondii is inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylase

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Pathogenesis of toxoplasmic retinochoroiditis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

A maternal screening program for congenital toxoplasmosis in Quindio, Colombia and application of mathematical models to estimate incidences using age-stratified data.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Ocular involvement in toxoplasmosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

In vitro effects of artemisinin ether, cycloguanil hydrochloride (alone and in combination with sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondii

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazine

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Long term ocular and neurological involvement in severe congenital toxoplasmosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Pneumocystis pneumonia: importance of gallium scan for early diagnosis and description of a new immunoperoxidase technique to demonstrate Pneumocystis carinii

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Theoretical bases of the prevention by spiramycin of congenital toxoplasmosis in pregnant women

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Manifestations and management of ocular toxoplasmosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Toxoplasmosis in pregnancy and its transmission to the fetus

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Estimating income losses and other preventable costs caused by congenital toxoplasmosis in people in the United States

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Diagnostic aspects of neonatal ascites: report of 27 cases

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Probable Transmission of Toxoplasma gondii by Organ Transplantation

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Hydrops fetales and congenital toxoplasmosis. Value of direct immunofluorescence test

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegaloviral and toxoplasma infections

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Congenital toxoplasmosis in the newborn

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Human maternofoetal distribution of pyrimethamine-sulphadoxine

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Congenital toxoplasmosis. The Toxoplasmosis Study Group

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Congenital toxoplasmosis: a significant cause of neurological morbidity in Israel?

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

On the problem of the etiological importance of toxoplasmosis in hearing disorders, especially in deaf-mutism

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Radiologic Study of Intracranial Calcifications in Congenital Toxoplasmosis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Congenital toxoplasmosis and deafness. An investigation

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

A study to determine causal relationships of toxoplasmosis to mental retardation

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Positive brain scan in toxoplasmosis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Subclinical central nervous system disease of neonates: a prospective study of infants born with increased levels of IgM.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Microbial causes of mental retardation. The role of prenatal infections with cytomegalovirus, rubella virus, and toxoplasma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

A correlative immunologic, microbiologic and clinical approach to the diagnosis of acute and chronic infections in newborn infants

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Five drug regimens for treatment of acute toxoplasmosis in squirrel monkeys.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Congenital toxoplasmosis. Clinical and neuroradiological evaluation of the cerebral lesions.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Congenital toxoplasmosis presenting as massive neonatal ascites.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar).

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Prenatal diagnosis of congenital toxoplasmosis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Pachygyriclike changes: topographic appearance at MR imaging and CT and correlation with neurologic status

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Absence of Sensorineural Hearing Loss in Treated Infants and Children with Congenital Toxoplasmosis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

An unusually high prevalence of ocular toxoplasmosis in southern Brazil

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Toxoplasmosis presenting as brain abscesses. Diagnosis by computerized tomography and cytology of aspirated purulent material

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

The Effect of Trimethoprim and Sulfamethoxazole on Toxoplasma Gondii in Vitro and in Vivo *

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

A treatable cause of hydrops fetalis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Termination of pregnancy for maternal toxoplasmosis

28 July 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Toxoplasmosis and mental retardation--report of a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Congenital toxoplasmosis. A prospective study of 378 pregnancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Biological and genetic characterisation of Toxoplasma gondii isolates from chickens (Gallus domesticus) from São Paulo, Brazil: unexpected findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Toxoplasma gondii Isolates of Free-Ranging Chickens From Rio de Janeiro, Brazil: Mouse Mortality, Genotype, and Oocyst Shedding by Cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Serial changes in a patient with congenital CNS toxoplasmosis as observed with CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Unusual abundance of atypical strains associated with human ocular toxoplasmosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Ocular manifestations in congenital toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

HLA-class II genes modify outcome of Toxoplasma gondii infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Update on unethical use of placebos in randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Central diabetes insipitus in a patient with congenital toxoplasmosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America)

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

A multihousehold study reveals a positive correlation between age, severity of ocular toxoplasmosis, and levels of glycoinositolphospholipid-specific immunoglobulin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Chorioretinopathy associated with other evidence of cerebral damage in childhood; a syndrome of unknown etiology separable from congenital toxoplasmosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Radiological signs in newborns exposed to primary Toxoplasma infection in utero

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Long-term ocular prognosis in 327 children with congenital toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

The International Congress on Toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Hearing loss in congenital toxoplasmosis detected by newborn screening.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Severe toxoplasmosis caused by a Toxoplasma gondii strain with a new isoenzyme type acquired in French Guyana.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Neurologic and developmental outcome in treated congenital toxoplasmosis.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Congenital toxoplasmosis: long-term follow-up.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Late neurological development of congenital toxoplasmosis demonstrated by study of the CSF

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735102

Genotype of 86Toxoplasma gondiiIsolates Associated with Human Congenital Toxoplasmosis, and Correlation with Clinical Findings

29 November 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

Commentary: Efficacy of prenatal treatment for toxoplasmosis: a possibility that cannot be ruled out

21 January 2018

1 reference

12 December 2020

Congenital toxoplasmosis complicated by central diabetes insipidus in an infant with Down syndrome

1 reference

12 December 2020

[Congenital toxoplasmosis. Prospective study of the outcome of pregnancy in 542 women with toxoplasmosis acquired during pregnancy]

1 reference

12 December 2020

Long-term follow-up of patients with congenital ocular toxoplasmosis

1 reference

12 December 2020

Toxoplasmosis in children. A study of 83 Swedish cases

1 reference

12 December 2020

Computed tomography in the evaluation of congenital cerebral toxoplasmosis

1 reference

12 December 2020

Intellectual deficits in children born with subclinical congenital toxoplasmosis: a preliminary report

1 reference

12 December 2020

[In utero treatment of congenital toxoplasmosis with a pyrimethamine-sulfadiazine combination]

1 reference

12 December 2020

Failure of spiramycin to prevent neurotoxoplasmosis in immunosuppressed patients

1 reference

12 December 2020

Congenital toxoplasmosis simulating haemolytic disease of the newborn

1 reference

12 December 2020

[Congenital toxoplasmosis causing diabetes insipidus]

1 reference

12 December 2020

Congenital toxoplasmosis: prenatal diagnosis, treatment and postnatal outcome

1 reference

12 December 2020

Sexual precocity associated with congenital toxoplasmosis

1 reference

12 December 2020

STUDIES ON THE FREQUENCY OF A POSITIVE TOXOPLASMOSIS REACTION IN MENTALLY DEFICIENT, DEAF, AND NORMALLY DEVELOPED CHILDREN

1 reference

12 December 2020

Outcome for children infected with congenital toxoplasmosis in the first trimester and with normal ultrasound findings: a study of 36 cases

1 reference

12 December 2020

Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening

1 reference

12 December 2020

An evaluation of the curative effects of pyrimethamine and sulfadiazine, alone and in combination, on experimental mouse toxoplasmosis

1 reference

12 December 2020

[Toxoplasmosis as a cause of mental deficiency]

1 reference

12 December 2020

[Contribution of health check-ups in children to the detection and epidemiologic study of congenital toxoplasmosis]

1 reference

12 December 2020

Time to Screen for Congenital Toxoplasmosis?

1 reference

12 December 2020

Toxoplasmosis in pregnancy

1 reference

12 December 2020

LATE EVOLUTIVE OUTBREAKS OF CONGENITAL TOXOPLASMOSIS

1 reference

12 December 2020

A CASE OF CONGENITAL TOXOPLASMIC MENINGOENCEPHALITIS COMPLICATED BY AN EDEMATOUS FORM OF SYMPTOMATIC ERYTHROBLASTOSIS

1 reference

12 December 2020

Eye manifestations of congenital toxoplasmosis

1 reference

12 December 2020

[Effect of pyrimethamine sulfadoxine (Fansidar) on an avirulent cystogenic strain of Toxoplasma gondii (Prugniaud strain) in white mice]

1 reference

12 December 2020

[Congenital toxoplasmosis with dermatitis calcificans toxoplasmatica and tetany of the mother during delivery]

1 reference

12 December 2020

[Fetal death and hydrops universalis caused by toxoplasmosis]

1 reference

12 December 2020

Synergistic effect of sulfadiazine and daraprim against experimental toxoplasmosis in the mouse

1 reference

12 December 2020

Ultrasonic diagnosis of fetal ascites and toxoplasmosis

1 reference

12 December 2020

Prevention of congenital toxoplasmosis

1 reference

12 December 2020

[A homogeneous series of 210 cases of congenital toxoplasmosis in 0 to 11-month-old infants detected prospectively]

1 reference

12 December 2020

[Partial anterior hypopituitarism caused by toxoplasmosis congenita. Description of a clinical case]

1 reference

12 December 2020

Congenital toxoplasmosis 38 years ago

1 reference

12 December 2020

Congenital toxoplasmosis mimicking a cerebral tumor. Special aspects in serodiagnostics of connatal toxoplasmosis (author's transl)

1 reference

12 December 2020

Effect of pyrimethamine and sulfadiazine on the fine structure and multiplication of Toxoplasma gondii in cell cultures

1 reference

12 December 2020

Longitudinal study of new eye lesions in treated congenital toxoplasmosis

1 reference

12 December 2020

[Congenital nephrotic syndrome associated with congenital toxoplasmosis]

1 reference

12 December 2020

Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria

1 reference

12 December 2020

The relative activity of the common sulfonamides against experimental toxoplasmosis in the mouse

1 reference

12 December 2020

Evaluation of the possibilities for preventing congenital toxoplasmosis

1 reference

12 December 2020

1 reference

12 December 2020

Effects of Trimethoprim and Sulfisoxazole Alone and in Combination on Murine Toxoplasmosis

1 reference

12 December 2020

Results of 20-year follow-up of congenital toxoplasmosis

1 reference

12 December 2020

Antitoxoplasmic activity of sulfonamides with various radicals in experimental toxoplasmosis in mice

1 reference

12 December 2020

Congenital toxoplasmosis presenting with eosinophilic meningitis

1 reference

12 December 2020

Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment

1 reference

12 December 2020

Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid

1 reference

12 December 2020

Central nervous system toxoplasmosis

1 reference

12 December 2020

[Experimental toxoplasmosis in mice. Comparative activity of clindamycin, midecamycin, josamycin, spiramycin, pyrimethamine-sulfadoxine, and trimethoprim-sulfamethoxazole]

1 reference

12 December 2020

Toxoplasmosis: the time has come

1 reference

12 December 2020

Hypothalamo-pituitary dysfunction in congenital toxoplasmosis

1 reference

12 December 2020

High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study

1 reference

12 December 2020

1st practical experiences in the prevention of congenital toxoplasmosis

1 reference

12 December 2020

Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study

1 reference

12 December 2020

Repeated isolation of toxoplasma from the cerebrospinal fluid and from the blood, and the antibody response in four cases of congenital toxoplasmosis

1 reference

12 December 2020

[Ocular prognosis in congenital toxoplasmosis: the role of treatment. Preliminary communication]

1 reference

12 December 2020

The effect of sulfadimetine, sulfisoxazole, and sulfapyrazine against mouse toxoplasmosis

1 reference

12 December 2020

Perinatal infections of the central nervous system

1 reference

12 December 2020

The simultaneous occurrence of congenital toxoplasmosis and congenital myxoedema

1 reference

12 December 2020

Relative reversal by vitamins (rho-aminobenzoic, folic, and folinic acids) of the effects of sulfadiazine and pyrimethamine on Toxoplasma, mouse and man

1 reference

12 December 2020

Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling

1 reference

12 December 2020

Screening methods for congenital toxoplasma and risk of disease

1 reference

12 December 2020

[Toxoplasmosis surveillance during pregnancy in Austria--results and problems]

1 reference

12 December 2020

The risk of HIV transmission by screened blood

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000200029

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1590/S0074-02762009000200029

1 reference

release_yfpkaasarbhqrkthhd6mvuf3gi

2431774

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yfpkaasarbhqrkthhd6mvuf3gi

24 November 2022

mapped directly with Wikidata item

2431774

1 reference

1 reference

1 reference